The Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents (SECURIPLAN)

August 3, 2018 updated by: Centre Hospitalier Universitaire, Amiens

Randomized Controlled Trial of the Effectiveness of the Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents

The recommendation for the treatment of suicidal adolescents, Cognitive Behavioral Therapy (CBT) targeted new generation offer effective approaches to suicidal crisis and relapse prevention

Study Overview

Detailed Description

The recommendation for the treatment of suicidal adolescents, Cognitive Behavioral Therapy (CBT) targeted new generation offer effective approaches to suicidal crisis and relapse prevention.

Since 2009, our team is engaged in a partnership between France and Quebec Interuniversity agreement concluded by a University Picardie Jules Verne-University of Montreal. In this context, two teams G4 (Amiens and Rouen) have received training in suicidal crisis, including the security plan by a university instructor and TCC Québec, Dr. Labelle. Furthermore, we complete a descriptive and prospective study of risk and protective factors for adolescent suicide in which the Quebec team of Professor Labelle contributes as an expert (sponsor: Rouen). 200 subjects were recruited on 2 years by 3 (CHU Amiens, CH Compiègne, CHU Rouen) with an assessment of recurrence at 1 year (lost rates of view = 15%). The first results highlight the central role of personal coping strategies (coping) in suicidal recurrence. We want extend this study to validate the implementation of the security plan (safety level) with suicidal adolescents. The security plan is the initial step of the TCC approach short of suicidal crisis. It is established after working with adolescents and their families (chain analysis of the suicidal crisis, coping self-evaluation and identification of support resources). Developed by Stanley B from Columbia University and adapted for francophone adolescents R Labelle and JJ Breton wrote this list those resources and coping strategies to apply in case ideation and suicidal crisis. Signed by the young person and his family, he then uses to frame the monitoring and management plan of the youth and his family environment, friendly and professional in case of suicidal crisis.

Study Type

Interventional

Enrollment (Anticipated)

338

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Amiens, France, 80000
        • Recruiting
        • CHU Amiens Picardie
        • Contact:
          • Jean-marc GUILE, PhD
        • Sub-Investigator:
          • Sébatien GARNY DE LA RIVIERE, Dr
      • Caen, France, 14000
        • Recruiting
        • CHU caen
        • Contact:
          • Jean-marc BALEYTE, PhD
        • Sub-Investigator:
          • Solène SPIERS, Dr
      • Rouen, France, 76000
        • Recruiting
        • CHU Charles Nicolle
        • Contact:
          • Priscille GERARDIN, PhD
        • Sub-Investigator:
          • Malaika Lasfar, Dr
        • Sub-Investigator:
          • Agathe Raynal, Dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adolescents between 12 and 17, boys and girls, hospitalized for attempted suicide
  • Adolescents whose parents gave informed consent and who themselves expressed their willingness to participate in research.
  • Patients covered by the social insurance system

Exclusion Criteria:

  • Clinical situations with self-injury without suicidal intent or suicide attempt
  • mental disorders significantly impair the self-assessment questionnaire capacities: Intellectual disability, autism spectrum disorder, acute psychotic state and, psychopathy (including assessment questionnaire Frick) and the active use of alcohol and toxic (DEP teen> 20)
  • have benefited a security plan before the study
  • adolescents deprived of liberty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: security plan
groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with security plan and the usual treatment
This study compared two groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with the Security Plan plus the usual treatment and a group receiving standard treatment only.
Active Comparator: standard treatment only.
group receiving standard treatment only.
This study compared two groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with the Security Plan plus the usual treatment and a group receiving standard treatment only.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of suicide attempt
Time Frame: 12 months
Occurrence of suicide attempt recurrence (documented by CNRS) during the year following randomization.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of relapse Suicide attempt
Time Frame: 6 months
Occurrence of relapse Suicide attempt within 6 months of randomization.
6 months
Observance
Time Frame: 6 months and 12 months
Observance at 6 months and 1 year using the categories used in the Giraud study
6 months and 12 months
coping strategies of the adolescent
Time Frame: 12 months
Compare at 1 year the evolution of coping strategies of the adolescent assessed by changes in coping scores assessed by self-questionnaire Friedenberg (ACS) from randomization to 1 year later.
12 months
Evolution of social support perceived by the teen evaluat
Time Frame: 12 months
Compare at 1 year evolution of social support perceived by the teen evaluated by varying the scores of self-questionnaire Sarason (SSQ6) from randomization to 1 year later.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jean-Marc GUILE, professor, CHU Amiens-Picardie
  • Principal Investigator: LEGRAND, Doctor, CHP Philippe Pinel Amiens
  • Principal Investigator: GERARDIN, Doctor, CHU de Rouen
  • Principal Investigator: BALEYTE, Doctor, University Hospital, Caen
  • Principal Investigator: Bernadette BAKHACHE, Doctor, CH St-Quentin
  • Principal Investigator: Maud PERCQ, Doctor, EPSMD Aisne
  • Principal Investigator: VERVEL, Doctor, CH Compiègne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2017

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

November 10, 2016

First Submitted That Met QC Criteria

November 10, 2016

First Posted (Estimate)

November 15, 2016

Study Record Updates

Last Update Posted (Actual)

August 6, 2018

Last Update Submitted That Met QC Criteria

August 3, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PI2015_843_0009

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Treatment of Suicidal Recidivism in Adolescents Population

Clinical Trials on Security Plan

3
Subscribe